Barbora Peltanová
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Otorhinolaryngology top 10%
Papers in
-
- Cancer, Hypoxia, and Metabolism 4
- MicroRNA in disease regulation 1
- Oncology 3
- Cancer Cells and Metastasis 3
- Cancer-related Molecular Pathways 2
- Co-authors
- Michal Masařík (6 shared papers)Martina Raudenská (6 shared papers)Hana Polanská (4 shared papers)Jiří Navrátil (3 shared papers)Dalibor Pacík (1 shared paper)Lenka Radová (1 shared paper)Jan Doležel (1 shared paper)Ondřej Slabý (1 shared paper)
- Journals
- Cancers (1 paper)Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (1 paper)Journal of Cellular and Molecular Medicine (1 paper)ACS Applied Materials & Interfaces (1 paper)Molecular Cancer (1 paper)
- Partner nations
- CzechiaGermanyNetherlands
In The Last Decade
Barbora Peltanová
7 papers receiving 462 citations
Peers
Comparison fields: 5 of 59
- Cancer Research 128
- Otorhinolaryngology 29
- Oncology 171
- Immunology 100
- Periodontics 12
Countries citing papers authored by Barbora Peltanová
This map shows the geographic impact of Barbora Peltanová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbora Peltanová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbora Peltanová more than expected).
Fields of papers citing papers by Barbora Peltanová
This network shows the impact of papers produced by Barbora Peltanová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbora Peltanová. The network helps show where Barbora Peltanová may publish in the future.
Co-authors
The 25 scholars most cited alongside Barbora Peltanová, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 331 | |
| 2 | 2022 | 58 | |
| 3 | 2018 | 35 | |
| 4 | 2021 | 23 | |
| 5 | 2022 | 10 | |
| 6 | 2021 | 9 | |
| 7 | 2022 | 2 | |
| 8 | 2026 | 0 |
About Barbora Peltanová
Barbora Peltanová is a scholar working on Cancer Research, Oncology, Surgery, Molecular Biology and Urology, having authored 8 papers that have together received 468 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (4 papers), Cancer Cells and Metastasis (3 papers), Cancer-related Molecular Pathways (2 papers), MXene and MAX Phase Materials (1 paper), Urinary and Genital Oncology Studies (1 paper), MicroRNA in disease regulation (1 paper), Metabolomics and Mass Spectrometry Studies (1 paper) and Mathematical Biology Tumor Growth (1 paper). The work is most often cited by research in Cancer Research (128 citations), Otorhinolaryngology (29 citations), Oncology (171 citations), Immunology (100 citations) and Periodontics (12 citations). Barbora Peltanová has collaborated with scholars based in Czechia, Germany and Netherlands. Frequent co-authors include Michal Masařík, Martina Raudenská, Hana Polanská, Jiří Navrátil, Dalibor Pacík, Lenka Radová, Jan Doležel, Ondřej Slabý, Michal Staník and Marek Svoboda. Their work appears in journals such as Cancers, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, Journal of Cellular and Molecular Medicine, ACS Applied Materials & Interfaces and Molecular Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.